deltatrials
Completed PHASE3 NCT00000150

Submacular Surgery Trials (SST)

Sponsor: National Eye Institute (NEI)

Conditions Histoplasmosis Macular Degeneration
Interventions Subfoveal Choroidal Neovascularization Removal
Updated 5 times since 2017 Last updated: Sep 16, 2009 Started: Jan 31, 1999 Completion: Sep 30, 2001

This PHASE3 trial investigates Histoplasmosis and Macular Degeneration and is currently completed. National Eye Institute (NEI) leads this study, which shows 5 recorded versions since 1999 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Jan 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Eye Institute (NEI)
Data source: National Eye Institute (NEI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.